66 related articles for article (PubMed ID: 1371513)
1. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line.
Gamet L; Murat JC; Remaury A; Remesy C; Valet P; Paris H; Denis-Pouxviel C
J Cell Physiol; 1992 Mar; 150(3):501-9. PubMed ID: 1371513
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells.
Kim SW; Beauchamp RD; Townsend CM; Thompson JC
Surgery; 1991 Aug; 110(2):270-5; discussion 276. PubMed ID: 1713357
[TBL] [Abstract][Full Text] [Related]
3. Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin.
Roger PP; Servais P; Dumont JE
J Cell Physiol; 1987 Jan; 130(1):58-67. PubMed ID: 3027108
[TBL] [Abstract][Full Text] [Related]
4. Dual effects of glucagon and cyclic AMP on DNA synthesis in cultured rat hepatocytes: stimulatory regulation in early G1 and inhibition shortly before the S phase entry.
Thoresen GH; Sand TE; Refsnes M; Dajani OF; Guren TK; Gladhaug IP; Killi A; Christoffersen T
J Cell Physiol; 1990 Sep; 144(3):523-30. PubMed ID: 2167904
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
[TBL] [Abstract][Full Text] [Related]
6. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
8. cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1.
Blomhoff HK; Blomhoff R; Stokke T; deLange Davies C; Brevik K; Smeland EB; Funderud S; Godal T
J Cell Physiol; 1988 Dec; 137(3):583-7. PubMed ID: 2848044
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
11. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL
Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity.
Gamet L; Cazenave Y; Trocheris V; Denis-Pouxviel C; Murat JC
Int J Cancer; 1991 Feb; 47(4):633-8. PubMed ID: 1847359
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
[TBL] [Abstract][Full Text] [Related]
14. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
Leung BS; Potter AH
J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of cell proliferation and C-myc cancer protein expression in human colon adenocarcinoma cell line HT29 with VIP-131I-ASON].
Ou X; Tan T; Li Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1096-100. PubMed ID: 17121362
[TBL] [Abstract][Full Text] [Related]
16. Influence of melatonin on chicken lymphocytes in vitro: involvement of membrane receptors.
Markowska M; Mrozkowiak A; Skwarlo-Sonta K
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():67-72. PubMed ID: 12019355
[TBL] [Abstract][Full Text] [Related]
17. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells.
Aharoni D; Dantes A; Oren M; Amsterdam A
Exp Cell Res; 1995 May; 218(1):271-82. PubMed ID: 7537693
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and aveolar type II cell lineage: Implications for chemoprevention.
Adissu HA; Schuller HM
Int J Oncol; 2004 Jun; 24(6):1467-72. PubMed ID: 15138589
[TBL] [Abstract][Full Text] [Related]
19. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression.
Charollais RH; Mester J
J Cell Physiol; 1988 Dec; 137(3):559-64. PubMed ID: 3142887
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization, and biological activity of somatostatin receptors in human neuroblastoma cell lines.
Maggi M; Baldi E; Finetti G; Franceschelli F; Brocchi A; Lanzillotti R; Serio M; Camboni MG; Thiele CJ
Cancer Res; 1994 Jan; 54(1):124-33. PubMed ID: 8261433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
